| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 42 |
| 1 | METHOTREXATE | 38 |
| 2 | METFORMIN | 22 |
| 3 | ASPIRIN | 20 |
| 4 | ASPIRIN 325 MG | 20 |
| 5 | ASPIRIN 81 MG | 20 |
| 6 | GABAPENTIN | 20 |
| 7 | HYDROCORTISONE | 18 |
| 8 | ANTI ITCH | 17 |
| 9 | ANTI-ITCH | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIPRAMINE HYDROCHLORIDE | 2 | 0.0035 |
| 1 | DIFELIKEFALIN | 1 | 0.0024 |
| 2 | ASIAN GINSENG | 1 | 0.0024 |
| 3 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0015 |
| 4 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 5 | 12%AZELAIC ACID | 1 | 0.0012 |
| 6 | OLANZAPINE AND SAMIDORPHAN L-MALATE | 2 | 0.0012 |
| 7 | OLEZARSEN SODIUM | 1 | 0.0011 |
| 8 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 9 | BESIFLOXACIN | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 1 | Corticosteroid [EPC] | 37 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 3 | Atypical Antipsychotic [EPC] | 24 |
| 4 | Benzodiazepine [EPC] | 20 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 20 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 7 | Interleukin-23 Antagonist [EPC] | 13 |
| 8 | Opioid Agonist [EPC] | 12 |
| 9 | Provitamin D2 Compound [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 9 | 0.0013 |
| 2 | Methylating Agent [EPC] | 1 | 0.0010 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 3 | 0.0006 |
| 4 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 2 | 0.0006 |
| 5 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 6 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 7 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 8 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 7 | 0.0003 |
| 9 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |